SS

Satadal Sengupta

Active Director Director DIN 09437118
DIN 09437118 First appointment Dec 2021 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Satadal Sengupta

Data last updated:

Satadal Sengupta is a Director at Orgrameen Bioproducts Private Limited (since 2021). The company operates in Agriculture.

DIN 09437118
Primary Designation Director
Industry Agriculture
First Appointment 15 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 20212021Active

Board colleagues of Satadal Sengupta

NameDINCompanyDesignation
Kasturi Mandal09548352Orgrameen Bioproducts Private LimitedAdditional Director
Swastika Das10149234Orgrameen Bioproducts Private LimitedDirector

Directorship timeline

Open interactive timeline →
Orgrameen Bioproducts Private Limited
Premium access

Shareholding and investment profile for Satadal Sengupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satadal Sengupta

Satadal Sengupta currently holds 1 directorship: Orgrameen Bioproducts Private Limited (Director, since 15 Dec 2021).

Satadal Sengupta was first appointed on 15 Dec 2021 as Director at Orgrameen Bioproducts Private Limited.

The current boards of Satadal Sengupta's companies include Kasturi Mandal (Orgrameen Bioproducts Private Limited), Swastika Das (Orgrameen Bioproducts Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available